ETC
AXSM icon

Exchange Traded Concepts’s Axsome Therapeutics AXSM Stock Holding History

Exchange Traded Concepts’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Sell
589
-21
-3% -$4.55K ﹤0.01% 1427
2026
Q1 		$103K Buy
+610
New +$105K ﹤0.01% 1367

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Exchange Traded Concepts's AXSM Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Axsome Therapeutics (AXSM) stake by 3.4% in Q2 2026, selling an estimated $4.55K and leaving 589 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #1427.

Exchange Traded Concepts first reported a position in AXSM in Q1 2026 and has held it in 2 quarters since. 53 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Exchange Traded Concepts held 589 shares of Axsome Therapeutics worth $144K as of Q2 2026.
  • Exchange Traded Concepts sold 21 Axsome Therapeutics shares in Q2 2026, an estimated $4.55K.
  • Axsome Therapeutics made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #1427 holding.
  • Exchange Traded Concepts first reported a position in Axsome Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 53 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.